Operator
Good evening, and welcome to Oyster Point Pharma s first-quarter 2021 earnings conference call. My name is Sarah, and I will be your operator today. After the company s formal remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to Mr.
Daniel Lochner, Oyster Point Pharma s chief financial officer. Please go ahead.
Dan Lochner
Chief Financial Officer
Good evening, everyone, and welcome to the Oyster Point Pharma first-quarter earnings conference call for the three months ending March 31, 2021. This issued a press release containing our first-quarter financial results and recent business highlights. In addition, our earnings press release and our Form 10-Q that was filed with the SEC after the close of the market today are available on our website under the investor and news section at www.oysterpointrx.com. Joining us on our call today are Dr.